These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9096591)

  • 1. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers.
    Yang D; Alt E; Rogler CE
    Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
    Liu P; Zhao Z; Dominique B
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.
    Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA
    Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
    Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
    Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
    Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
    Mol Carcinog; 2002 Oct; 35(2):93-102. PubMed ID: 12325039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth.
    Schirmacher P; Held WA; Yang D; Chisari FV; Rustum Y; Rogler CE
    Cancer Res; 1992 May; 52(9):2549-56. PubMed ID: 1568224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
    Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
    Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY; Factor VM; Thorgeirsson SS
    Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene].
    Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C
    Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG; Goldsworthy TL; Cattley RC
    Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration.
    Coni P; Simbula G; de Prati AC; Menegazzi M; Suzuki H; Sarma DS; Ledda-Columbano GM; Columbano A
    Hepatology; 1993 Jun; 17(6):1109-16. PubMed ID: 8514261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.